APA (7th ed.) Citation

PR, R., L, L., V, S., A, C., MJ, B., N, C., . . . A, M. F. (2025). The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: A single-centre retrospective analysis. Frontiers in oncology, 15, 1579602. https://doi.org/10.3389/fonc.2025.1579602

Chicago Style (17th ed.) Citation

PR, Rodrigues, Lopes-Conceição L, Sousa V, Coutada A, Bento MJ, Coimbra N, Leal C, Pereira D, and Magalhães Ferreira A. "The Clinicopathological Characteristics, Oncologic Outcomes and Costs of "HER2-low" Early Breast Cancer Compared to HER2-zero and HER2-positive: A Single-centre Retrospective Analysis." Frontiers in Oncology 15 (2025): 1579602. https://doi.org/10.3389/fonc.2025.1579602.

MLA (9th ed.) Citation

PR, Rodrigues, et al. "The Clinicopathological Characteristics, Oncologic Outcomes and Costs of "HER2-low" Early Breast Cancer Compared to HER2-zero and HER2-positive: A Single-centre Retrospective Analysis." Frontiers in Oncology, vol. 15, 2025, p. 1579602, https://doi.org/10.3389/fonc.2025.1579602.